The management of chronic pain in important patient subgroups

Clinical Drug Investigation
Paolo CherubinoRoberto Labianca

Abstract

Chronic pain is a major healthcare issue in Europe and globally, and inadequate or undertreated pain significantly reduces the ability of many patients to participate in ordinary daily activities, adversely affects their employment status and contributes to a substantial rate of depression and anxiety in patients with chronic pain. There is a broad distinction of chronic pain into chronic non-cancer pain and chronic cancer pain, and important subgroups of these include patients with rheumatic and/or orthopaedic diseases, pain syndromes caused by cancer itself and caused by cancer treatment. Despite comprising the majority of non-cancer pain in Europe, chronic non-cancer pain associated with rheumatic diseases and/or orthopaedic conditions is often inadequately managed. Although paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs) play a continuing role in the treatment of chronic rheumatic diseases, accumulating evidence of potential toxicity with both traditional non-selective NSAIDs and selective cyclooxygenase 2 inhibitors has prompted a reassessment of their use. This has particular resonance for the elderly, who are more likely to have significant pain issues than younger patients and are at high risk of NSAID-re...Continue Reading

References

Dec 18, 1998·Psychiatric Services : a Journal of the American Psychiatric Association·D A Monti, E J Kunkel
Apr 28, 2000·Cancer Control : Journal of the Moffitt Cancer Center·J M Regan, P Peng
Jul 19, 2001·Clinics in Geriatric Medicine·K A Herr, L Garand
Feb 13, 2002·Arthritis and Rheumatism·UNKNOWN American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines
Dec 5, 2003·Postgraduate Medical Journal·V K PodichettyR S Biscup
Oct 9, 2004·Annals of the Rheumatic Diseases·W ZhangUNKNOWN EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
Nov 18, 2004·JAMA : the Journal of the American Medical Association·Don L GoldenbergLeslie Crofford
Aug 13, 2005·European Journal of Pain : EJP·Harald BreivikDerek Gallacher
May 24, 2006·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Andrea D FurlanEldon Tunks
Jun 3, 2006·Clinical Rheumatology·Thomas J Schnitzer
May 8, 2007·Journal of Pain and Symptom Management·Frank Brennan
Jun 2, 2007·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Raj KumarSamir Kumar Kalra
Jul 24, 2007·Annals of the Rheumatic Diseases·S F CarvilleUNKNOWN EULAR
May 28, 2008·Pharmacotherapy·Christopher M HerndonUNKNOWN Ambulatory Care, Cardiology, and Pain and Palliative Care Practice and Research Networks of the American College of Clinical
Jul 18, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S DeandreaG Apolone
Feb 4, 2009·The Journal of Pain : Official Journal of the American Pain Society·Roger ChouUNKNOWN American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel
Feb 27, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H BreivikL Dow
Apr 2, 2009·Neuropsychiatric Disease and Treatment·Kim Lawson
Jul 2, 2009·Mayo Clinic Proceedings·Howard S Smith
Jul 4, 2009·Journal of the American Geriatrics Society·UNKNOWN American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons
Jul 17, 2009·Current Opinion in Anaesthesiology·Esther M Pogatzki-ZahnStephan A Schug
Apr 20, 2010·Annals of the New York Academy of Sciences·L J LangC Baerwald
Oct 16, 2010·Current Opinion in Gastroenterology·Siew C Ng, Francis K L Chan
Jan 13, 2011·BMJ : British Medical Journal·Sven TrellePeter Jüni
Mar 15, 2011·The Journal of Pain : Official Journal of the American Pain Society·Keela Herr
Oct 20, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C I RipamontiUNKNOWN ESMO Guidelines Working Group
Mar 6, 2012·Clinical Drug Investigation·Renato Vellucci
Mar 6, 2012·Clinical Drug Investigation·Diego Fornasari

❮ Previous
Next ❯

Citations

Jan 16, 2014·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Stefano TamburinAndreas Goebel
Jun 22, 2013·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Greg T Carter
Jun 10, 2015·Pharmacology, Biochemistry, and Behavior·Zhi XiaoMeng-Jie Sun
Apr 21, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·En-Ling Leung Ki, Francis K L Chan
Aug 13, 2015·Best Practice & Research. Clinical Rheumatology·Piercarlo Sarzi-PuttiniSerge Perrot
Nov 30, 2016·Naunyn-Schmiedeberg's Archives of Pharmacology·Aleksandra Janas, Joanna Folwarczna
Feb 1, 2019·The American Journal on Addictions·Thomas R Kosten, Louis E Baxter
Mar 22, 2014·The Korean Journal of Internal Medicine·Roberto PuentePablo Reyes
Oct 3, 2017·Rheumatology·Ramin RaoofNiels Eijkelkamp
Jun 20, 2018·Drugs & Aging·Paola MianMirko Petrovic
Jan 13, 2021·Trends in Molecular Medicine·Annemieke Kavelaars, Cobi J Heijnen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.